WESTON, Fla., June 5, 2020 /PRNewswire/ - Apotex is expanding the previously announced Retail Level recall of Metformin Hydrochloride Extended-Release Tablets, USP 500mg that was initiated on May 29, ...
The US Food and Drug Administration (FDA) has recommended voluntary recall of certain extended-release (ER) versions of metformin because testing has revealed excessive levels of ...
Issue: Products contain or may contain a nitrosamine impurity, N-nitrosodimethylamine (NDMA), above or close to the acceptable limit. What to do: You should not stop taking your metformin drug without ...
Two pharmaceutical companies recently issued voluntary recalls for extended-release versions of the diabetes drug metformin, because it may contain high levels of a cancer-causing chemical, according ...
For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...
The polycystic ovary syndrome (PCOS) is defined as the presence of both ovulatory dysfunction and hyperandrogenism. In women with PCOS, oligo- or anovulation manifests itself as irregular cycles with ...
Two pharmaceutical companies recently issued voluntary recalls for extended-release versions of the diabetes drug metformin, because it may contain high levels of a cancer-causing chemical, according ...
Apotex Inc. is voluntarily recalling nine additional lots of its prescription metformin drug, APO-METFORMIN ER (extended release) 500mg tablets. Company test results showed one of the lots (PY7174) ...
For the above reasons, Medindia cannot be held liable for any action taken based on the information provided by its website. The purpose of this website is to provide initial guidance only and it does ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback